These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
453 related items for PubMed ID: 29453384
1. Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease. Gracie DJ, Hamlin JP, Ford AC. Am J Gastroenterol; 2018 May; 113(5):702-712. PubMed ID: 29453384 [Abstract] [Full Text] [Related]
2. Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 6 years of longitudinal follow-up. Fairbrass KM, Hamlin PJ, Gracie DJ, Ford AC. Aliment Pharmacol Ther; 2022 Oct; 56(8):1264-1273. PubMed ID: 35995729 [Abstract] [Full Text] [Related]
3. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease. Gracie DJ, Williams CJ, Sood R, Mumtaz S, Bholah MH, Hamlin PJ, Ford AC. Clin Gastroenterol Hepatol; 2017 Mar; 15(3):376-384.e5. PubMed ID: 27189912 [Abstract] [Full Text] [Related]
5. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity. Berrill JW, Green JT, Hood K, Campbell AK. Aliment Pharmacol Ther; 2013 Jul; 38(1):44-51. PubMed ID: 23668698 [Abstract] [Full Text] [Related]
6. Depression and Somatization Are Associated With Increased Postprandial Symptoms in Patients With Irritable Bowel Syndrome. Van Oudenhove L, Törnblom H, Störsrud S, Tack J, Simrén M. Gastroenterology; 2016 Apr; 150(4):866-74. PubMed ID: 26602216 [Abstract] [Full Text] [Related]
7. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners. Abdalla MI, Sandler RS, Kappelman MD, Martin CF, Chen W, Anton K, Long MD. Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305 [Abstract] [Full Text] [Related]
8. Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease. Fairbrass KM, Selinger CP, Gracie DJ, Ford AC. Neurogastroenterol Motil; 2022 May; 34(5):e14256. PubMed ID: 34472157 [Abstract] [Full Text] [Related]
9. The impact of physical complaints, social environment, and psychological functioning on IBS patients' health perceptions: looking beyond GI symptom severity. Lackner JM, Gudleski GD, Thakur ER, Stewart TJ, Iacobucci GJ, Spiegel BM. Am J Gastroenterol; 2014 Feb; 109(2):224-33. PubMed ID: 24419481 [Abstract] [Full Text] [Related]
10. Reflux and irritable bowel syndrome are negative predictors of quality of life in coeliac disease and inflammatory bowel disease. Barratt SM, Leeds JS, Robinson K, Shah PJ, Lobo AJ, McAlindon ME, Sanders DS. Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):159-65. PubMed ID: 21178777 [Abstract] [Full Text] [Related]
17. Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome. Goodoory VC, Mikocka-Walus A, Yiannakou Y, Houghton LA, Black CJ, Ford AC. Am J Gastroenterol; 2021 Jul 01; 116(7):1485-1494. PubMed ID: 33840729 [Abstract] [Full Text] [Related]